| Summary points: | A 66-year-old with a family history of Alzheimer's disease is treated with a cholinesterase inhibitor following two years of short-term memory decline. This case discusses the disease's progress, objective measurements of dysfunction, and patient management, and a review of current treatments. |
Advances in the Pharmacotherapy of Alzheimer's Disease
